To investigate the timeline and nature of antibody production in newborns compared to maternal antibody transfer.
Key Findings:
At birth, infant serum was dominated by maternal IgG1, while IgA1 was nearly absent.
By 7-11 weeks postpartum, infant serum contained new IgA1 and IgG1 antibodies that did not overlap with maternal sources.
IgA1 detected in infant circulation is produced by the infant, not absorbed from breast milk.
A significant fraction of new, infant-specific IgG1 clones appeared within the first two to three months of life.
Milk IgA primarily acts at mucosal surfaces and does not enter the infant bloodstream.
Interpretation:
Infant antibody production begins earlier than previously thought, suggesting a rapid establishment of systemic humoral immunity independent of maternal antibodies.
Limitations:
The study involved a small sample size of only four mother-infant pairs.
Further research is needed to generalize findings across diverse populations.
Conclusion:
The findings have implications for understanding neonatal immune development and could influence future vaccination strategies.
